Booster Therapeutics
Developer of a new class of proteasome activator medicines.
1
Funding Rounds
$15.0m
Money raised
Overview
Developer of a new class of proteasome activator medicines.
- Website:
- Headquarters: Berlin
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Di*** Fe******* |
|
- | |
| Da*** Tr**** | - | - | - |
Funding series
Funding Series Analysis
The company Booster Therapeutics has raised a total of $15m in funding over 1 rounds.
Key Insights:
- Booster Therapeutics Seed Round, October 2024: $15m
Booster Therapeutics Seed Round, October 2024
$15m